FDA advisors endorse Alzheimer’s treatment Leqembi paving way for full approval this summer
Medicare has promised to broadly cover Leqembi, which costs $26,500 per year, if the FDA grants full approval of the
Read More
Biotechnology
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that
Read More
FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage
The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.
Read More
FDA considers temporary cancer drug imports from unapproved companies to ease U.S. shortage
Shortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs. Source link
Read More
FDA approves Pfizer RSV vaccine for older adults
The approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a
Read More
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
Danuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection
Read More
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus
Read More
Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
The authors said the estimated cost of Leqembi to Medicare are conservative, and spending on the Alzheimer's treatment may increase
Read More
Americans in most states will no longer receive Covid exposure notifications on phones
Apple and Google's Covid exposure notification system aimed to help millions of Americans trace infections and make decisions about isolating
Read More